Gene therapy for rheumatoid arthritis: preclinical studies

Author(s):  
Sergei S. Makarov
Author(s):  
F. Apparailly ◽  
P. Plence ◽  
D. Noel ◽  
C. Jorgensen

2021 ◽  
Vol 9 (5) ◽  
pp. 1070
Author(s):  
Alok K. Paul ◽  
Anita Paul ◽  
Rownak Jahan ◽  
Khoshnur Jannat ◽  
Tohmina A. Bondhon ◽  
...  

Rheumatoid arthritis is a chronic autoimmune disorder that can lead to disability conditions with swollen joints, pain, stiffness, cartilage degradation, and osteoporosis. Genetic, epigenetic, sex-specific factors, smoking, air pollution, food, oral hygiene, periodontitis, Prevotella, and imbalance in the gastrointestinal microbiota are possible sources of the initiation or progression of rheumatoid arthritis, although the detailed mechanisms still need to be elucidated. Probiotics containing Lactobacillus spp. are commonly used as alleviating agents or food supplements to manage diarrhea, dysentery, develop immunity, and maintain general health. The mechanism of action of Lactobacillus spp. against rheumatoid arthritis is still not clearly known to date. In this narrative review, we recapitulate the findings of recent studies to understand the overall pathogenesis of rheumatoid arthritis and the roles of probiotics, particularly L. casei or L. acidophilus, in the management of rheumatoid arthritis in clinical and preclinical studies.


2009 ◽  
Vol 17 (11) ◽  
pp. 1877-1887 ◽  
Author(s):  
Jeroen Geurts ◽  
Leo AB Joosten ◽  
Nozomi Takahashi ◽  
Onno J Arntz ◽  
Anton Glück ◽  
...  

Author(s):  
Thomas S. Muzzonigro ◽  
Richard Kang ◽  
Julio Reinecke ◽  
Peter Wehling ◽  
Mary C. Wasko ◽  
...  

1998 ◽  
Vol 20 (1-2) ◽  
pp. 197-209 ◽  
Author(s):  
Paul D. Robbins ◽  
Christopher H. Evans ◽  
Yuti Chernajovsky

Author(s):  
S. Vassilieva ◽  
A. Shmidt ◽  
A. Starikova ◽  
M. Bardina

In the present work we validated neonatal intracerebroventricular injections for AAV-mediated transgene delivery into GNAO1-rich regions of the murine brain. This administration route can be used for testing efficacy of AAV- based gene therapy for GNAO1 encephalopathy in the mouse models.


2016 ◽  
Vol 36 (2) ◽  
pp. 149-161 ◽  
Author(s):  
Shuang Liu ◽  
Kazutaka Maeyama

Biomedicines ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 9 ◽  
Author(s):  
Andrei A. Deviatkin ◽  
Yulia A. Vakulenko ◽  
Ludmila V. Akhmadishina ◽  
Vadim V. Tarasov ◽  
Marina I. Beloukhova ◽  
...  

Rheumatoid arthritis (RA) is a systemic inflammatory joint disease affecting about 1% of the population worldwide. Current treatment approaches do not ensure a cure for every patient. Moreover, classical regimens are based on nontargeted systemic immune suppression and have significant side effects. Biological treatment has advanced considerably but efficacy and specificity issues remain. Gene therapy is one of the potential future directions for RA therapy, which is rapidly developing. Several gene therapy trials done so far have been of moderate success, but experimental and genetics studies have yielded novel targets. As a result, the arsenal of gene therapy tools keeps growing. Currently, both viral and nonviral delivery systems are used for RA therapy. Herein, we review recent approaches for RA gene therapy.


Sign in / Sign up

Export Citation Format

Share Document